Cargando…

KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models

Loss of function KCNK3 mutation is one of the gene variants driving hereditary pulmonary arterial hypertension (PAH). KCNK3 is expressed in several cell and tissue types on both membrane and endoplasmic reticulum and potentially plays a role in multiple pathological process associated with PAH. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	West, James D., Austin, Eric D., Rizzi, Elise M., Yan, Ling, Tanjore, Harikrishna, Crabtree, Amber L., Moore, Christy S., Muthian, Gladson, Carrier, Erica J., Jacobson, David A., Hamid, Rizwan, Kendall, Peggy L., Majka, Susan, Rathinasabapathy, Anandharajan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126011/ https://www.ncbi.nlm.nih.gov/pubmed/34065088 http://dx.doi.org/10.3390/ijms22095014

Ejemplares similares

Expression of a Human Caveolin-1 Mutation in Mice Drives Inflammatory and Metabolic Defect-Associated Pulmonary Arterial Hypertension
por: Rathinasabapathy, Anandharajan, et al.
Publicado: (2020)

rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling
por: Rathinasabapathy, Anandharajan, et al.
Publicado: (2018)

Overexpression of Msx1 in Mouse Lung Leads to Loss of Pulmonary Vessels Following Vascular Hypoxic Injury
por: West, James, et al.
Publicado: (2021)

Ubiquitin chains: a new way of screening for regulatory differences in pulmonary hypertension
por: Rathinasabapathy, Anandharajan, et al.
Publicado: (2018)

2-Aminoethoxydiphenyl borate activates the mechanically gated human KCNK channels KCNK 2 (TREK-1), KCNK 4 (TRAAK), and KCNK 10 (TREK-2)
por: Beltrán, Leopoldo, et al.
Publicado: (2013)

Identification and characterization of two zebrafish Twik related potassium channels, Kcnk2a and Kcnk2b
por: Nasr, Nathalie, et al.
Publicado: (2018)

Epigenetic Dysregulation of KCNK9 Imprinting and Triple-Negative Breast Cancer
por: Skaar, David A., et al.
Publicado: (2021)

The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury
por: Rathinasabapathy, Anandharajan, et al.
Publicado: (2018)

KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma
por: Li, Wen-Chao, et al.
Publicado: (2019)

Effects of the ventilatory stimulant, doxapram on human TASK‐3 (KCNK9, K2P9.1) channels and TASK‐1 (KCNK3, K2P3.1) channels
por: Cunningham, Kevin P., et al.
Publicado: (2019)

Rapid disease progress in a PVOD patient carrying a novel EIF(2)AK(4) mutation: a case report
por: Zeng, Xiaofang, et al.
Publicado: (2020)

ALKBH5-mediated m(6)A demethylation of KCNK15-AS1 inhibits pancreatic cancer progression via regulating KCNK15 and PTEN/AKT signaling
por: He, Yuan, et al.
Publicado: (2021)

Opening and Closing of KcnkØ Potassium Leak Channels Is Tightly Regulated
por: Zilberberg, Noam, et al.
Publicado: (2000)

Functional analysis of missense variants in the TRESK (KCNK18) K(+) channel
por: Andres-Enguix, Isabelle, et al.
Publicado: (2012)

Gain-of-function mutations in KCNK3 cause a developmental disorder with sleep apnea
por: Sörmann, Janina, et al.
Publicado: (2022)

A KCNK16 mutation causing TALK-1 gain of function is associated with maturity-onset diabetes of the young
por: Graff, Sarah M., et al.
Publicado: (2021)

Pulmonary veno-occlusive disease in Sjogren's syndrome: a case report
por: Zeng, Xiaofang, et al.
Publicado: (2023)

Allelic chromatin structure primes imprinted expression of Kcnk9 during neurogenesis
por: Loftus, Daniel, et al.
Publicado: (2023)

NGS Nominated CELA1, HSPG2, and KCNK5 as Candidate Genes for Predisposition to Balkan Endemic Nephropathy
por: Toncheva, D., et al.
Publicado: (2014)

KCNK5 channels mostly expressed in cochlear outer sulcus cells are indispensable for hearing
por: Cazals, Yves, et al.
Publicado: (2015)

Integrative Analysis of KCNK Genes and Establishment of a Specific Prognostic Signature for Breast Cancer
por: Zou, Yutian, et al.
Publicado: (2022)

KCNK9 mediates the inhibitory effects of genistein on hepatic metastasis from colon cancer
por: Cheng, Yuan, et al.
Publicado: (2023)

Expanding the phenotypic spectrum of KCNK4: From syndromic neurodevelopmental disorder to rolandic epilepsy
por: Yan, Hong-Jun, et al.
Publicado: (2023)

Association of cardiac injury with hypertension in hospitalized patients with COVID-19 in China
por: Zeng, Xiaofang, et al.
Publicado: (2021)

KCNK18 Biallelic Variants Associated with Intellectual Disability and Neurodevelopmental Disorders Alter TRESK Channel Activity
por: Pavinato, Lisa, et al.
Publicado: (2021)

Proteomic Analysis of KCNK3 Loss of Expression Identified Dysregulated Pathways in Pulmonary Vascular Cells
por: Le Ribeuz, Hélène, et al.
Publicado: (2020)

Potassium Channel Protein KCNK6 Promotes Breast Cancer Cell Proliferation, Invasion, and Migration
por: Hou, Xiangchan, et al.
Publicado: (2021)

Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis
por: Chu, Ling-Hui, et al.
Publicado: (2022)

Role of hippocampal circKcnk9 in visceral hypersensitivity and anxiety comorbidity of irritable bowel syndrome
por: Liu, Yuan, et al.
Publicado: (2022)

Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension
por: West, James, et al.
Publicado: (2020)

A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis
por: Sun, Han, et al.
Publicado: (2016)

Pharmacoinformatics elucidation of potential drug targets against migraine to target ion channel protein KCNK18
por: Sehgal, Sheikh Arslan, et al.
Publicado: (2014)

The Impact of Heterozygous KCNK3 Mutations Associated With Pulmonary Arterial Hypertension on Channel Function and Pharmacological Recovery
por: Bohnen, Michael S., et al.
Publicado: (2017)

The correlation and role analysis of KCNK2/4/5/15 in Human Papillary Thyroid Carcinoma microenvironment
por: Lin, Xu, et al.
Publicado: (2020)

KCNK3 inhibits proliferation and glucose metabolism of lung adenocarcinoma via activation of AMPK-TXNIP pathway
por: Lin, Guofu, et al.
Publicado: (2022)

Crosstalk between BMP signaling and KCNK3 in phenotypic switching of pulmonary vascular smooth muscle cells
por: Yeo, Yeongju, et al.
Publicado: (2022)

OR28-3 A Mutation in KCNK16 Segregating with Autosomal Dominant Non-Ketotic Diabetes Drastically Increases TALK-1 Membrane Current: A Novel Gene for MODY?
por: Johnson, Stephanie, et al.
Publicado: (2019)

Gain and loss of TASK3 channel function and its regulation by novel variation cause KCNK9 imprinting syndrome
por: Cousin, Margot A., et al.
Publicado: (2022)

Syndromic disorders caused by gain-of-function variants in KCNH1, KCNK4, and KCNN3—a subgroup of K(+) channelopathies
por: Gripp, Karen W., et al.
Publicado: (2021)

Hydroxy-α sanshool induces colonic motor activity in rat proximal colon: a possible involvement of KCNK9
por: Kubota, Kunitsugu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mba6sln4jkiuhgtqimitf14d9r